FLII and Ewing sarcoma: Furthermore, treatment of Ewing sarcoma cell lines with the potent and reversible LSD1 inhibitor HCI-2509, comprehensively reversed the transcriptional profiles driven by both EWS-FLI and EWS-ERG and significantly delayed tumorigenesis in vivo [22].